| SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | 
| 
									SCHEDULE 13G
								 | 
| 
							UNDER THE SECURITIES EXCHANGE ACT OF 1934
					 | 
| Tvardi Therapeutics, Inc. (Name of Issuer) | 
| Common Stock, par value $0.001 per share (Title of Class of Securities) | 
| 140755208 (CUSIP Number) | 
| 04/15/2025 (Date of Event Which Requires Filing of this Statement) | 
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: | 
|  Rule 13d-1(b) | 
|  Rule 13d-1(c) | 
|  Rule 13d-1(d) | 
| 
								SCHEDULE 13G
							 | 
| CUSIP No. | 140755208 | 
| 1 | Names of Reporting Persons Sporos Bioventures LLC | ||||||||
| 2 | Check the appropriate box if a member of a Group (see instructions)  (a)  (b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization 
				DELAWARE
			 | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: | 
 | ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting Person 837,636.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)  | ||||||||
| 11 | Percent of class represented by amount in row (9) 8.95 %  | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO | 
| 
								SCHEDULE 13G
							 | 
| Item 1. | ||
| (a) | Name of issuer: Tvardi Therapeutics, Inc. | |
| (b) | Address of issuer's principal executive offices: 3 Sugar Creek Ctr Blvd, Ste 525, Sugar Land, Texas, 77478 | |
| Item 2. | ||
| (a) | Name of person filing: Sporos Bioventures LLC | |
| (b) | Address or principal business office or, if none, residence: 3139 West Holcombe Blvd, Houston, Texas, 77025 | |
| (c) | Citizenship: Delaware | |
| (d) | Title of class of securities: Common Stock, par value $0.001 per share | |
| (e) | CUSIP No.: 140755208 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) |  Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |
| (b) |  Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |
| (c) |  Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |
| (d) |  Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |
| (e) |  An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) |  An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) |  A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) |  A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | |
| (i) |  A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) |  A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: | |
| (k) |  Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). | |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned: Sporos Bioventures LLC directly owns 837,636 shares of Common Stock | |
| (b) | Percent of class: 8.95  %
							 | |
| (c) | Number of shares as to which the person has: | |
| (i) Sole power to vote or to direct the vote: 837,636 | ||
| (ii) Shared power to vote or to direct the vote: 0 | ||
| (iii) Sole power to dispose or to direct the disposition of: 837,636 | ||
| (iv) Shared power to dispose or to direct the disposition of: 0 | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
| 
							Not Applicable
						 | ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
| 
								Not Applicable
							 | ||
| Item 8. | Identification and Classification of Members of the Group. | |
| 
								Not Applicable
							 | ||
| Item 9. | Notice of Dissolution of Group. | |
| 
								Not Applicable
							 | ||
| Item 10. | Certifications: | 
| 
									Not Applicable
							 | 
| SIGNATURE | |
| 
						After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
						 | 
| 
 | 
| 
 |